Suono Bio - Ultrasonic Enhanced Delivery Technology
We have reimagined ultrasound as a simple and effective delivery platform, which acts on the therapeutic molecules themselves, achieving ultra-rapid, formulation-independent drug delivery. This enables us to “push” virtually any therapeutic class, including temperamental molecules, like nucleic acids, directly into cells with astounding efficacy and accuracy, affecting historically "undruggable" targets. We harness the power of ultrasound-induced cavitation to achieve this delivery and are applying it to creating new treatments for a variety of diseases, starting with inflammatory conditions.
Platform Flexibility
By enabling truly formulation-independent drug delivery, we can apply the technology to numerous therapeutic classes for a range of disease states. This allows us to rapidly expand and advance our therapeutic pipeline with new programs addressing additional indications. Our current pipeline leverages clinically proven disease targets to advance superior treatments.
Faster Development
Our technology removes the complexities and challenges of delivery from the drug development process, enabling a rapid acceleration of development. This means that the best drug compound may be advanced regardless of its chemical properties.
- Fluidic bubble formation in the presence of a large pressure gradient
- As pressure increases bubbles collapse resulting in “jetting”
- Jetting drives surrounding fluid into adjacent surface
- When fluid contains a compound and the adjacent surface is tissue, the compound is driven into the tissue
- Formulation-independent, ultra-rapid delivery of small molecules, biologics, and nucleic acids
- Demonstrated safety in small and large animal models
- Superior efficacy in a preclinical disease models